1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study (
- Serum kidney injury molecule 1 and β2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes (
- 2017
- Automated pathway and reaction prediction facilitates in silico identification of unknown metabolites in human cohort studies (
- 2016
- Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes (
- 2015
- Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. (
- Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes. (
- Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes (